AVAX Technologies
Philadelphia
About AVAX Technologies
Avax Technologies, Inc is a based biotechnology company whose most advanced product candidate is MVax for melanoma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Ticker: otcpink:AVXT
- Website: avax-tech.com
- Phone: (215)241-9760
Canonical: https://fsome.com/organization/avax-technologies-3373301 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.